| Primary |
| Contraception |
51.1% |
| Menstruation Irregular |
10.6% |
| Menstrual Cycle Management |
4.3% |
| Menstrual Disorder |
4.3% |
| Oral Contraception |
4.3% |
| Ovarian Cyst |
4.3% |
| Acne |
2.1% |
| Dysmenorrhoea |
2.1% |
| Headache |
2.1% |
| Menorrhagia |
2.1% |
| Multiple Sclerosis |
2.1% |
| Polycystic Ovaries |
2.1% |
| Polymenorrhoea |
2.1% |
| Thyroid Disorder |
2.1% |
| Uterine Haemorrhage |
2.1% |
| Uterine Leiomyoma |
2.1% |
|
| Pulmonary Embolism |
22.0% |
| Thrombosis |
12.2% |
| Coeliac Disease |
7.3% |
| Deep Vein Thrombosis |
7.3% |
| Metrorrhagia |
7.3% |
| Weight Increased |
7.3% |
| Vomiting |
4.9% |
| Cerebral Disorder |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Convulsion |
2.4% |
| Death |
2.4% |
| Delivery |
2.4% |
| Drug Dose Omission |
2.4% |
| Drug Effect Decreased |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Dysfunctional Uterine Bleeding |
2.4% |
| Eye Disorder |
2.4% |
| Haemorrhage |
2.4% |
| Hypersensitivity |
2.4% |
| Hypertension |
2.4% |
|
| Secondary |
| Contraception |
33.3% |
| Drug Use For Unknown Indication |
30.0% |
| Idiopathic Thrombocytopenic Purpura |
6.7% |
| Post Coital Contraception |
6.7% |
| Acne |
3.3% |
| Adverse Event |
3.3% |
| Ankylosing Spondylitis |
3.3% |
| Epilepsy |
3.3% |
| Hypersensitivity |
3.3% |
| Muscle Cramps |
3.3% |
| Product Used For Unknown Indication |
3.3% |
|
| Wisdom Teeth Removal |
30.0% |
| Drug Level Below Therapeutic |
10.0% |
| Goitre |
10.0% |
| Menstruation Irregular |
10.0% |
| Ovarian Cyst |
10.0% |
| Pelvic Pain |
10.0% |
| Ureteric Dilatation |
10.0% |
| Vertigo |
10.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.2% |
| Contraception |
14.2% |
| Asthma |
7.6% |
| Acne |
5.4% |
| Oral Contraception |
5.2% |
| Drug Use For Unknown Indication |
5.0% |
| Crohn's Disease |
4.6% |
| Multiple Allergies |
4.1% |
| Anxiety |
3.4% |
| Depression |
2.9% |
| Pain |
2.6% |
| Post Coital Contraception |
2.5% |
| Psoriasis |
2.5% |
| Psoriatic Arthropathy |
2.5% |
| Premenstrual Syndrome |
2.4% |
| Menstrual Cycle Management |
2.2% |
| Premedication |
2.1% |
| Hypertension |
1.7% |
| Hepatitis C |
1.5% |
| Fibromyalgia |
1.4% |
|
| Pain |
12.2% |
| Menstruation Irregular |
9.2% |
| Injection Site Pain |
7.1% |
| Nausea |
6.1% |
| Road Traffic Accident |
6.1% |
| Cholelithiasis |
5.1% |
| Injury |
5.1% |
| Vomiting |
5.1% |
| Weight Increased |
5.1% |
| Wrong Technique In Drug Usage Process |
5.1% |
| Pulmonary Embolism |
4.1% |
| Rash |
4.1% |
| Urticaria |
4.1% |
| Headache |
3.1% |
| Injection Site Swelling |
3.1% |
| Loss Of Consciousness |
3.1% |
| Malaise |
3.1% |
| Nasopharyngitis |
3.1% |
| Oropharyngeal Pain |
3.1% |
| Pain In Extremity |
3.1% |
|
| Interacting |
|
|
